Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found ...
Researchers discovered that SARS-CoV-2-specific T and B cells in long COVID patients are maintained for two years, similar to ...
According to The Independent, 500 samples from 27 countries, including Poland, Norway, Luxembourg, Ukraine, Portugal, and ...
A new long-term study into long COVID has investigated how a certain population of white blood cells, called memory T cells, ...
SARS-CoV-2, the pandemic virus that causes COVID-19, has mutated endlessly since it burst on the scene in late 2019. An new ...
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...
The complex and ever-evolving immunity landscape associated with SARS-CoV-2, combined with immune evasion by omicron ...
An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains.
Researchers uncover how SARS-CoV-2 exposure stabilizes BMI in adults, offering crucial insights into the pandemic's lasting ...